Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.51 GBX -1.28% Market Closed
Market Cap: 76.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Creo Medical Group PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Creo Medical Group PLC
Cost of Revenue Peer Comparison

Comparables:
SN
LIVN
EKF
AGL
B
BELL

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Cost of Revenue
-ÂŁ15.3m
CAGR 3-Years
-8%
CAGR 5-Years
-449%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Cost of Revenue
-$1.7B
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Cost of Revenue
-$400.1m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-31%
EKF Diagnostics Holdings PLC
LSE:EKF
Cost of Revenue
-ÂŁ26.5m
CAGR 3-Years
10%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Angle PLC
LSE:AGL
Cost of Revenue
-ÂŁ626k
CAGR 3-Years
-51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Belluscura PLC
LSE:BELL
Cost of Revenue
-$1.8m
CAGR 3-Years
N/A
CAGR 5-Years
-48%
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Cost of Revenue?
Cost of Revenue
-15.3m GBP

Based on the financial report for Jun 30, 2024, Creo Medical Group PLC's Cost of Revenue amounts to -15.3m GBP.

What is Creo Medical Group PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-449%

Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for Creo Medical Group PLC have been -8% over the past three years , -449% over the past five years .

Back to Top